+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases



JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases



Vascular Pharmacology 43(5): 357-363



They were more than just another kinases (JAK), when they were first described in the late 80s and named JAK kinases. The mandatory role of this novel family of dual active janus kinases (JAK) and their substrates the signal transducers and activators of transcription (STAT) was demonstrated in mice who died during embryogenesis when lacking a functional allele, e.g. that of JAK2. Initially, the JAK/STAT signaling pathway was discovered as the primary mediator of intracellular signaling induced by interferon in hematopoietic and immune cells. Nowadays, it is well accepted that JAK kinases and STAT proteins are constitutively expressed in the vessel wall in a cell type specific manner and transfer intracellular signaling events of various receptor families, e.g. that of cytokines, growth factors and vasoactive peptides such as angiotensin II (Ang II) or endothelin. The potential impact of the JAK/STAT signaling pathway on cardiovascular pathophysiology and disease development arise from reports describing that JAKs may bind directly to the angiotensin II type I (AT(1)) receptor, thereby enhancing their phosphorylation in various cell types of the vessel wall. More interestingly, these signaling events are modulated by NAD(P)H oxidase-derived superoxide anions which directly phosphorylate JAK2 and thereby control JAK2 activity. A potential impact was also described for atherosclerotic plaque development in which the activation of JAKs and STATs seems to be critical. Based on these observations, we here review the role of the JAK/STAT signaling pathways as critical regulator for cardiovascular disease development, i.e. atherosclerotic plaque progression or the manifestation of arterial hypertension.

(PDF emailed within 0-6 h: $19.90)

Accession: 049427638

Download citation: RISBibTeXText

PMID: 16271517

DOI: 10.1016/j.vph.2005.08.021


Related references

Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochemical Journal 351(Pt 1): 257-264, 2000

JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases. Seminars in Cutaneous Medicine and Surgery 37(3): 198-208, 2018

Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clinical Immunology: -, 2016

A Janus Kinase in the JAK/STAT signaling pathway from Litopenaeus vannamei is involved in antiviral immune response. Fish & Shellfish Immunology 44(2): 662-673, 2016

Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Molecular Endocrinology 14(5): 662-670, 2000

Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. Journal of Immunology 168(12): 6506-6513, 2002

Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. Journal of Biological Chemistry 274(45): 32382-6, 1999

Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. Journal of Immunology 166(5): 3491-3498, 2001

The JAK-STAT pathway in hypertrophic stress signaling and genomic stress response. Jak-Stat 1(2): 131-141, 2012

Constitutive association of Grb-2, key adaptor molecule of Ras signaling pathway, with STAT-5 or -6, transcription factors of Jak/STAT pathway, in hematopoietic and nonhematopoietic cell lines. Blood 94(10 SUPPL 1 PART 1): 473a, Nov 15, 1999

Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Current Drug Targets 9(5): 369-374, 2008

Constitutive association of ASH/GRB-2, key adaptor molecule of Ras signaling pathway, with STAT-5, transcription factor activated under JAK/STAT pathway, in hematopoietic and nonhematopoietic cell lines. Blood 92(10 SUPPL 1 PART 1-2): 577A, Nov 15, 1998

Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases. Current Signal Transduction Therapy 4(3): 201-221, 2009

CNTF and stress conditioning activate the Jak-STAT signaling pathway in rat retina. IOVS 41(4): S21, March 15, 2000

Role of a Janus kinase 2-dependent signaling pathway in platelet activation. Thrombosis Research 133(6): 1088-1096, 2015